Vitexin

未知生产厂商

生成 AI 研报

技术标识符

化学式: C₂₁H₂₀O₁₀
CAS 编号: 3681-93-4
UNII ID: 9VP70K75OK

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

PHARMACEUTICAL COMPOSITIONS AND METHODS FOR COUNTERING CHEMOTHERAPY INDUCED CARDIOTOXICITY
EP 3411017 A4申请人: STEM CELL THERANOSTICS INC优先权: 2016
CN
EP
US
WO
13 件公开
Method for preparing fine bamboo powder
US 11278585 B2申请人: SENLONG BIO TECH CO LTD优先权: 2017
CN
EP
US
WO
8 件公开
APPLICATION OF FLAVONOID C-GLYCOSIDE MONOMER COMPOUND
WO 2020043182 A1申请人: SHANGHAI INST BIOLOGICAL SCIENCES CAS优先权: 2018
CN
WO
4 件公开
COMPOUNDS WITH ANTI-AGING ACTIVITIES
US 2014301961 A1申请人: ORIFLAME RES AND DEV LTD优先权: 2011
CN
EP
US
3 件公开
METHOD AND COMPOSITION FOR TREATMENT OF CANCER
EP 4673158 A1申请人: IMPACT HEALTH GLOBAL LTD优先权: 2023
EP
US
WO
3 件公开
Therapeutic agents containing cannabis flavonoid derivatives for the prevention and treatment of neurodegenerative disorders
US 10751320 B2申请人: FLAVOCURE BIOTECH LLC优先权: 2015
US
WO
3 件公开
PROCESS FOR PRODUCTION OF ORALLY INGESTIBLE COMPOSITION CONTAINING ARABINOFURANOSYL VITEXIN, AND USE OF THE COMPOSITION
US 2012004193 A1申请人: KUSANO SHUICHI优先权: 2009
CN
US
2 件公开
Therapeutic agents containing cannabis flavonoid derivatives targeting kinases, sirtuins and oncogenic agents for the treatment of cancers
- US 11141401 B2
  申请人: LOWE HENRY优先权: 2015
  US
  WO
  2 件公开
- US 10398674 B2
  申请人: FLAVOCURE BIOTECH LLC优先权: 2015
  US
Method for preventing and/or treating the cardiovascular and hepatic diseases induced by hyperlipidemia which comprises administered an effective amount of bioflavonoids extract derived from fructus crataegus (lipid metabolism and fructus crataegus)
US 2006040911 A1申请人: LIAO BENEDICT S优先权: 2003
US
2 件公开
Low side effect pharmaceutical composition containing isoniazid
US 8304394 B2申请人: HU YOAPU OLIVER优先权: 2008
US
2 件公开

药物

Vitexin

专利

Therapeutic agents containing cannabis flavonoid derivatives targeting kinases, sirtuins and oncogenic agents for the treatment of cancers